These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The importance of quality appraisal in meta-analysis. Mahady SE; Webster AC Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1057; author reply 1057-8. PubMed ID: 22503999 [No Abstract] [Full Text] [Related]
23. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea. Biswal S Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712 [TBL] [Abstract][Full Text] [Related]
24. Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011. Kanerva M; Ollgren J; Voipio T; Mentula S; Lyytikäinen O Infect Dis (Lond); 2015 Aug; 47(8):530-5. PubMed ID: 25832317 [TBL] [Abstract][Full Text] [Related]
25. Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias. Novack L; Kogan S; Gimpelevich L; Howell M; Borer A; Kelly CP; Leffler DA; Novack V PLoS One; 2014; 9(10):e110790. PubMed ID: 25343667 [TBL] [Abstract][Full Text] [Related]
26. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711 [TBL] [Abstract][Full Text] [Related]
27. Editorial: PPIs and recurrent C. difficile infection: no association? Leontiadis GI Am J Gastroenterol; 2013 Nov; 108(11):1802-3. PubMed ID: 24192949 [TBL] [Abstract][Full Text] [Related]
29. Pathway to Prevention of Nosocomial Clostridium difficile Infection. Goldstein EJ; Johnson S; Maziade PJ; McFarland LV; Trick W; Dresser L; Millette M; Mazloum H; Low DE Clin Infect Dis; 2015 May; 60 Suppl 2():S148-58. PubMed ID: 25922401 [TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection. Nachnani JS; Bulchandani D; Allen MJ Indian J Gastroenterol; 2008; 27(4):171-2. PubMed ID: 18974472 [No Abstract] [Full Text] [Related]
31. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Naggie S; Miller BA; Zuzak KB; Pence BW; Mayo AJ; Nicholson BP; Kutty PK; McDonald LC; Woods CW Am J Med; 2011 Mar; 124(3):276.e1-7. PubMed ID: 21396512 [TBL] [Abstract][Full Text] [Related]
32. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292 [TBL] [Abstract][Full Text] [Related]
33. Proton Pump Inhibitors and Clostridium difficile Infection. Goyal H; Katner H Am J Gastroenterol; 2017 May; 112(5):805. PubMed ID: 28469228 [No Abstract] [Full Text] [Related]